Panacea Biotec
-
{
- All
- News
- Videos
-
India Close To Dengue Vaccine: All About The Phase 3 Trials And More
DengiAll, which is Panacea Biotec's tetravalent live-attenuated vaccine, uses weakened strains of all four DENV serotypes. As a single-dose shot, it simplifies administration compared to other multi-dose vaccines.
-
Someone From Russia Found Vaccine Maker In Himachal, Centre Failed: High Court
Delhi High Court expressed anguish over the way things have transpired in the 2nd wave of COVID-19 where vaccine shortage is hitting everyone even when the Centre says the best way to fight the pandemic is to vaccinate everyone.
-
COVID-19 Vaccine Sputnik V Production Launched In India
Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund has begun the production of Sputnik V COVID-19 vaccine in India, according to a joint statement issued today.
-
India's Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
-
Panacea Biotec To Partner With US-Based Refana Inc For COVID-19 Vaccine
Biotech firm Panacea Biotec Ltd said on Wednesday it would partner with US-based Refana Inc to make a potential vaccine for COVID-19.
-
India Close To Dengue Vaccine: All About The Phase 3 Trials And More
DengiAll, which is Panacea Biotec's tetravalent live-attenuated vaccine, uses weakened strains of all four DENV serotypes. As a single-dose shot, it simplifies administration compared to other multi-dose vaccines.
-
Someone From Russia Found Vaccine Maker In Himachal, Centre Failed: High Court
Delhi High Court expressed anguish over the way things have transpired in the 2nd wave of COVID-19 where vaccine shortage is hitting everyone even when the Centre says the best way to fight the pandemic is to vaccinate everyone.
-
COVID-19 Vaccine Sputnik V Production Launched In India
Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund has begun the production of Sputnik V COVID-19 vaccine in India, according to a joint statement issued today.
-
India's Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
-
Panacea Biotec To Partner With US-Based Refana Inc For COVID-19 Vaccine
Biotech firm Panacea Biotec Ltd said on Wednesday it would partner with US-based Refana Inc to make a potential vaccine for COVID-19.
